With hydroxychloroquine letting the world down at a time COVID-19 cases sprints towards unimaginable figures, scientists have been working harder to produce a cure.
Russia which had recorded no case as at valentine day has recently been overwhelmed with over 400, 000 cases and 3,000 deaths.
Their recoveries, almost half of the confirmed cases have been encouraging and their scientists seem to be doing something right.
On Friday June 5, Russia’s ministry of Health registered a new drug, levilimab with the trade name ILSIRA.
The drug in the class of antirheumatics or Rheumatism treatment drugs is produced by Russian company, BIOCAD.
Indeed, the drug has undergone testing for Rheumatoid arthritis since 2016.
It’s intended for the control of the severe stages of covid-19 known as cytokine storm.
Cytokine storm is the condition where the immune system overact to the presence of the virus. This causes the body’s soldiers to attack itself resulting in multiple organ failure. This is fingered in the deaths of many COVID-19 patients.
“I think we’ll be able to keep COVID-19 disease complications under control and minimize the harshest problems it causes,” general director of BIOCAD, Dmitry Morozov, wrote on Facebook.
The drug is delivered through the skin and available only for now at Russian hospitals.
Levilimab has been undergoing clinical trials since April, and has been approved by the Russian Federation.
According to the news medical life sciences, 11 healthcare centers have participated in clinical trial of the drug.
Out of the 36 patients undergoing treatment, 10 were discharged as early as on day 7 to 8 with 1 patient have to be transferred to the intensive care.
The full data is however yet to make their way into a peer-reviewed journal.
This becomes the second drug to be churned out by the country. Avifavir was also announced by ChemRar Group, A Russian Company on June 1.
In April 29 release, Gilead inc. manufacturers of antiviral Remdesvir announced results of phase 3 trial in patients with severe COVID-19
Latest Stories
-
Ghana shouldn’t have experienced any ‘dumsor’ after 2017 – IES Boss
49 mins -
Lamens flouted some food safety laws in re-bagging rice – Former FDA Boss Alhaji Hudu Mogtari
1 hour -
Afcon exit: Our issue is administrative failure and mismanagement, not lack of talent – Saddick Adams
2 hours -
WAPCo to commence major pipeline maintenance and inspection from November 25
2 hours -
CEO of Oro Oil Ghana Limited Maxwell Commey listed among the 100 Most Influential People Awards, 2024
2 hours -
Power crisis: Amandi is off due to maintenance, not debt – ECG Boss
2 hours -
Votes cast for late Akua Donkor to be declared invalid – Electoral Commission
2 hours -
You can’t keep “incompetent” Otto Addo for the long term – Countryman Songo
3 hours -
Joy FM holds 2024 Prayer Summit for Peace
3 hours -
Lady sues Police and AG over assault in custody
4 hours -
Ghana’s railway sector has been revived under my leadership – Akufo-Addo
4 hours -
Next government must enforce C190 – Women Economic Dialogue Forum
4 hours -
NCCE engages party youth activists at Nandom on peaceful election
5 hours -
SSNIT engages stakeholders on its operations
5 hours -
Defilement: 19-year-old farmer jailed ten years, with hard labour
5 hours